Ra mắt thuốc kháng thể chống COVID-19 có hiệu quả bảo vệ trong 6 tháng
Ngày 18/11, hãng dược phẩm AstraZeneca (Anh-Thụy Điển) cho biết thuốc kháng thể chống COVID-19 dạng tiêm mang tên Evusheld của hãng này cho hiệu quả bảo vệ lên đến 83% trong vòng 6 tháng.
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
(TTXVN/Vietnam+)